News

Viking Therapeutics Prepares for Key Investor Engagements Ahead

Viking Therapeutics Prepares for Key Investor Engagements Ahead

Viking Therapeutics Gears Up for Significant Investor Conferences

Viking Therapeutics, Inc. (NASDAQ: VKTX), based in San Diego, is an innovative biopharmaceutical company dedicated to advancing groundbreaking therapies aimed at addressing metabolic and endocrine disorders. The company is excited to announce its participation in two prominent upcoming investor conferences that will showcase their advancements and strategic vision.

Conference Participation Details

The company will be attending the following conferences:

Stifel 2025 Healthcare Conference

Viking's management team will engage in a fireside chat and host investor meetings. This conference is a crucial event for showcasing their progress and commitment to improving patient outcomes.

Conference Dates: November 11-13, 2025
Fireside Chat Schedule: November 11, 2025, from 4:40 PM to 5:10 PM Eastern Time
Location: New York, NY

Jefferies 2025 Global Healthcare Conference

This significant event will feature a corporate presentation by Viking management, along with various investor meetings, presenting an opportunity for deeper engagement.

Conference Dates: November 17-20, 2025
Presentation Schedule: November 19, 2025, from 8:00 AM to 8:25 AM Greenwich Mean Time
Location: London, UK

Webcast Availability

For those who cannot attend in-person, a live webcast of the Jefferies presentation will be accessible through the Viking Therapeutics website in the Investors & Media section. A recording of the presentation will also be available on their site following the conference, ensuring broadened access to vital information.

Understanding Viking Therapeutics' Vision

Viking Therapeutics is paving the way for innovative therapies targeting various metabolic and endocrine disorders. The core mission of the company is to leverage its scientific expertise to develop novel therapeutics that effectively enhance patient care and quality of life. They focus on creating first-in-class treatments, including their lead drug candidates.

One of their standout programs is VK2735, a dual agonist linked to GLP-1 and GIP receptors. This compound holds promise for the treatment of obesity, with ongoing Phase 3 clinical trials known as VANQUISH-1 and VANQUISH-2 currently under evaluation.

Preliminary results from earlier trials have shown VK2735 to have a satisfactory safety profile and early indicators of clinical assistance for patients. There are also plans in place for implementing an oral formulation of VK2735 in a Phase 2 trial focusing on obesity treatment.

Expanding Their Therapeutic Reach

Aside from VK2735, Viking is vigorously pursuing VK2809, a groundbreaking small molecule designed to target thyroid hormone receptor beta. This compound has shown exceptional efficacy in Phase 2 studies aimed at treating lipid and metabolic disorders.

In particular, VK2809 has achieved remarkable results in reducing specific fatty liver diseases and associated blood lipid levels, marking it as a pivotal player in Viking’s portfolio.

Additionally, the company is now exploring an array of dual amylin and calcitonin receptor agonists (DACRAs) for obesity treatment and other metabolic issues, showcasing their keen dedication to combatting these profound health challenges.

In rare disease contexts, VK0214 is being developed as an oral small molecule for potential use against X-linked adrenoleukodystrophy (X-ALD). Early-stage clinical trials have indicated that this compound is safe and well-tolerated, showcasing significant clinical activity in patients suffering from specific forms of this rare condition.

Commitment to Advancing Patient Care

Viking Therapeutics is unwavering in its commitment to reform and innovate patient care strategies surrounding metabolic disorders. Their promising pipeline continues to evolve, addressing significant unmet medical needs in patients. The participation in upcoming conferences illustrates Viking's strategic approach to sharing updates and connecting with investors who are as passionate about Improving Lives Through Innovation.

Frequently Asked Questions

What are the upcoming conferences Viking Therapeutics will attend?

Viking Therapeutics will participate in the Stifel 2025 Healthcare Conference and the Jefferies 2025 Global Healthcare Conference.

What is VK2735, and why is it significant?

VK2735 is a dual agonist linked to GLP-1 and GIP receptors, significant for its potential in treating obesity, with ongoing clinical trials underway.

Where can I access the Jefferies presentation?

A live webcast of the Jefferies presentation will be available on the Viking Therapeutics website under the Investors & Media section.

What other products is Viking Therapeutics developing?

The company is also advancing VK2809 for lipid and metabolic disorders and VK0214 for treating X-ALD.

How does Viking Therapeutics plan to engage with investors?

Viking Therapeutics is utilizing these conferences to present clinical advancements and share insights with investors, enhancing stakeholder connection and awareness.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Reap, Pivota, Meitu's AI Beauty Deal: Strategic MOU

Updated Category News Views 62

AI and Beauty Shopping: A New Era? In the buzzing world of tech and commerce, it looks like Reap, Pivota, and Meitu’s EveLab Insight have cooked up something that might just make the beauty shopping experience as slick and smart as a Wall Street trader on a good day. These three cats have signed a memorandum of understanding (MOU) to explore forging a path where...

Continue Reading
CData Software: A Challenger in Data Integration

Updated Category News Views 158

CData Software Earns Challenger Status Here we are, folks. CData Software just snagged the 'Challenger' title in the 2026 Gartner® Magic Quadrant™ for Data Integration Tools. For the uninitiated, that's a feather in the cap for these data wizards, proving they've got real skin in the game when it comes to connecting the data dots across enterprise landscapes. It’s...

Continue Reading
Veteran-Friendly U.S. Cities in 2026: Who's Leading?

Updated Category News Views 76

Veterans Find Their Business Groove in U.S. Cities Around the diner's counter, traders might be swapping tales of market victories or lamenting lost opportunities. But today, we're chewing over a different kind of success story—the top U.S. cities paving the way for veteran entrepreneurs, courtesy of a fresh report from the PenFed Foundation for Military Heroes. This...

Continue Reading
Major Rally Lifts Dow Amid Key Stock Moves

Updated Category News Views 90

Forget your usual day at the office, folks; Wednesday on Wall Street was anything but routine. The Dow Jones shot up a dazzling 1,572.58 points, reclaiming vital ground over an important technical threshold like the heavyweight it is. There's more cooking under the hood than mere index moves. We've got stocks jumping the charts like everyone's playing hopscotch, stirring...

Continue Reading
AI Governance Market to Hit $12.5B by 2030

Updated Category News Views 124

AI Governance: The Enforcer's Playground Well, with every Tom, Dick, and Harry out there tinkering with artificial intelligence, it's no shocker we've come to this. Peeled back, the AI governance platforms market's pegged to hit a whopping $12.5 billion by 2030. The AIMG's report spells this out with the kind of clarity even an intern could appreciate. But here's the rub:...

Continue Reading
Gastops and Anschütz: Boosting Canada's Submarine Project

Updated Category News Views 125

New Partnership on the Horizon for Canada’s Submarines In today's world, where defense contracts become the dance of global players, Gastops and Anschütz have clasped hands to join the orchestra. The news blew in from EURONAVAL 2026, where these two powerhouses in condition monitoring and missile systems, respectively, inked a fresh Memorandum of Understanding to back...

Continue Reading
AAN Seeks Donations to Drive Crucial Brain Research

Updated Category News Views 101

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

Continue Reading
Sae-A Trading Earns UNGC LEAD Recognition Again

Updated Category News Views 44

Another Year, Another Win for Sae-A Trading When was the last time you heard of an apparel manufacturer making waves for the right reasons? Sae-A Trading, the outfit under the Global Sae-A Group banner, is strutting its sustainability stuff by getting named as a UNGC LEAD Company for the second straight year. You better believe that’s not just for show – they’ve got...

Continue Reading
PropWallet: A Game Changer for Prop Firm Payouts?

Updated Category News Views 58

Change is Brewing in Boca Raton Well, folks, looks like PropAccount.com is shaking up the payout game with their latest brainchild, PropWallet. Launched on November 4, 2026, in sunny Boca Raton, they're setting the stage for a new way to handle payouts at prop trading firms. It's more than just another payout method; it's a ploy for keeping traders hooked and firms...

Continue Reading
A Journey Through Mongolia's Wilderness and Self-Discovery

Updated Category News Views 141

A Late-Life Adventure Without Borders We all hit that age where adventure seems just a memory—until something shakes us from our slumber, just like Betsy Cooksey’s wild ride into Mongolia. At an age when most tether their dreams to sunlit porches and grandkids' photos, Cooksey grabbed life by the reins. First, though, we gotta talk about the absolute gamble she took....

Continue Reading

Top 5 Most Recently Viewed Articles

Santa Claus Rally Anticipation: Key Market Insights

Updated Category News Views 199

Setting the Scene for the Santa Claus Rally This week is pivotal as it sets the stage for the much-anticipated Santa Claus rally. The upcoming Federal Reserve interest rate decision and accompanying press conference are expected to play a significant role. Analysts predict a rate cut of 25 basis points, leading investors to closely observe Chair Powell's remarks regarding...

Continue Reading
Japan's Ex-Currency Diplomat Kanda Chosen for ADB Leadership

Updated Category News Views 128

Japan Nominates Masato Kanda for ADB Leadership Role In a notable development, Japan has officially nominated Masato Kanda, the country’s former top currency diplomat, as its candidate for the leadership role at the Asian Development Bank (ADB). This announcement was made by Finance Minister Shunichi Suzuki, highlighting Japan's dedication to maintaining a strong...

Continue Reading
Airlines Adjust Schedules Amid Escalating Middle East Tensions

Updated Category News Views 76

Airlines Respond to Rising Tensions in the Middle East As tensions rise in the Middle East, international airlines are taking steps to protect their passengers and crew by either suspending or changing flights to the region. These actions reflect immediate safety concerns as well as strategic planning to respond to the ongoing situation. Flight Suspensions by Airlines...

Continue Reading
PrePass Intelligence: A Game-Changer for Fleets

Updated Category News Views 35

Picture this: you're at the wheel of a beastly 18-wheeler, barreling down the highway and skipping weigh stations thanks to PrePass. But here’s where the real magic kicks in. PrePass Intelligence just rolled out, aiming to squeeze every last drop of value from bypass and toll data. That's cold hard cash for fleet operators who can finally make sense of these fleeting...

Continue Reading
Titomic Expands European Footprint with New Facility Launch

Updated Category News Views 159

Titomic Expands European Footprint with New Facility Launch Titomic Limited (ASX: TTT), a global leader in Titomic Kinetic Fusion™, celebrated a major milestone through the grand opening of its state-of-the-art facility in Europe. This expansion signifies a pivotal moment for the company, showcasing its commitment to innovation in the field of cold spray additive...

Continue Reading